These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 20957015)

  • 21. Release behavior and photo-image of nifedipine tablet coated with high viscosity grade hydroxypropylmethylcellulose: effect of coating conditions.
    Cao QR; Choi HG; Kim DC; Lee BJ
    Int J Pharm; 2004 Apr; 274(1-2):107-17. PubMed ID: 15072787
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Release behavior of tanshinone IIA sustained-release pellets based on crack formation theory.
    Liu P; Li J; Liu J; Yang J; Fan Y
    J Pharm Sci; 2012 Aug; 101(8):2811-20. PubMed ID: 22610467
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimization of tamsulosin hydrochloride controlled release pellets coated with Surelease and neutralized HPMCP.
    Kim MS; Kim JS; Lee S; Jun SW; Park JS; Woo JS; Hwang SJ
    J Pharm Pharmacol; 2006 Dec; 58(12):1611-6. PubMed ID: 17331324
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pectin/Ethylcellulose as film coatings for colon-specific drug delivery: preparation and in vitro evaluation using 5-fluorouracil pellets.
    Wei H; Qing D; De-Ying C; Bai X; Fanli-Fang
    PDA J Pharm Sci Technol; 2007; 61(2):121-30. PubMed ID: 17479720
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of lipid and cellulose based matrix former on the release of highly soluble drug from extruded/spheronized, sintered and compacted pellets.
    Maboos M; Yousuf RI; Shoaib MH; Nasiri I; Hussain T; Ahmed HF; Iffat W
    Lipids Health Dis; 2018 Jun; 17(1):136. PubMed ID: 29885655
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Study of sustained-matrix tablets Ambroxol hydrochloride and potential impact of different fillers on the matrix tablet's scale-up].
    Wang MY; Yang YP; Chang JB; Guo MT
    Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Oct; 44(5):742-8. PubMed ID: 23073585
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of terbutaline sulfate sustained-release coated pellets.
    Umprayn K; Chitropas P; Amarekajorn S
    Drug Dev Ind Pharm; 1999 Apr; 25(4):477-91. PubMed ID: 10194603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of pulsatile multiparticulate drug delivery system coated with aqueous dispersion Aquacoat ECD.
    Mohamad A; Dashevsky A
    Int J Pharm; 2006 Aug; 318(1-2):124-31. PubMed ID: 16759827
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Preparation of gastric floating sustained-release capsules of Tripterygium wilfordii by using multiparticulate time-controlled release technology].
    Zhang W; Song H; Zhang Q
    Zhongguo Zhong Yao Za Zhi; 2009 Nov; 34(22):2867-71. PubMed ID: 20209947
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determination of the release mechanism of Theophylline from pellets coated with Surelease
    Kazlauske J; Cafaro MM; Caccavo D; Marucci M; Lamberti G; Barba AA; Larsson A
    Int J Pharm; 2017 Aug; 528(1-2):345-353. PubMed ID: 28583332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Studies on diclofenac sodium pulsatile release pellets].
    Guo T; Zheng CL; Song HT; Sui Y; Dang DS; Sun XH
    Yao Xue Xue Bao; 2003 Sep; 38(9):707-10. PubMed ID: 14730924
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Statistical optimization of tamsulosin hydrochloride controlled release pellets coated with the blend of HPMCP and HPMC.
    Kim JS; Kim MS; Park HJ; Lee S; Park JS; Hwang SJ
    Chem Pharm Bull (Tokyo); 2007 Jun; 55(6):936-9. PubMed ID: 17541199
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design and evaluation of pH-independent pulsatile release pellets containing isosorbide-5-mononitrate.
    Liu Y; Liu S; Dai Q
    Chem Pharm Bull (Tokyo); 2009 Jan; 57(1):55-60. PubMed ID: 19122316
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Direct compression of cushion-layered ethyl cellulose-coated extended release pellets into rapidly disintegrating tablets without changes in the release profile.
    Hosseini A; Körber M; Bodmeier R
    Int J Pharm; 2013 Dec; 457(2):503-9. PubMed ID: 23892153
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pulsatile systems for colon targeting of budesonide: in vitro and in vivo evaluation.
    Yehia SA; Elshafeey AH; Elsayed I
    Drug Deliv; 2011 Nov; 18(8):620-30. PubMed ID: 22111975
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Preparation of diltiazem hydrochloride delayed-onset, sustained release tablet].
    Zhang N; Zhu JB
    Yao Xue Xue Bao; 2002 Sep; 37(9):724-7. PubMed ID: 12567900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of a pulsatile release drug delivery system using different swellable/rupturable materials.
    El-Maradny HA
    Drug Deliv; 2007 Nov; 14(8):539-46. PubMed ID: 18027184
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Investigating effects of hydroxypropyl methylcellulose (HPMC) molecular weight grades on lag time of press-coated ethylcellulose tablets.
    Patadia R; Vora C; Mittal K; Mashru R
    Pharm Dev Technol; 2016 Nov; 21(7):794-802. PubMed ID: 26100758
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel system for three-pulse drug release based on "tablets in capsule" device.
    Li B; Zhu J; Zheng C; Gong W
    Int J Pharm; 2008 Mar; 352(1-2):159-64. PubMed ID: 18055142
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel approach to sustained pseudoephedrine release: differentially coated mini-tablets in HPMC capsules.
    Ishida M; Abe K; Hashizume M; Kawamura M
    Int J Pharm; 2008 Jul; 359(1-2):46-52. PubMed ID: 18467046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.